<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02038465</url>
  </required_header>
  <id_info>
    <org_study_id>5539</org_study_id>
    <nct_id>NCT02038465</nct_id>
  </id_info>
  <brief_title>Cognitive Remediation of Autobiographical Memory in Schizophrenia Using SenseCam®</brief_title>
  <acronym>RéMABSchiz</acronym>
  <official_title>REMEDIATION COGNITIVE DE LA MÉMOIRE AUTOBIOGRAPHIQUE DANS LA SCHIZOPHRENIE AU MOYEN DE SENSECAM</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to assess the efficiency of SenseCam® in patients with schizophrenia&#xD;
      by comparing two cognitive remediation methods of autobiographical memory.Patients and&#xD;
      control participants will be invited to carry SenseCam® during 7 hours per day minimum and&#xD;
      for 4 successive days. Each ending day when carry SenseCam®, they will be asked to go to the&#xD;
      laboratory where 4 types of interventions will be successively done according to the&#xD;
      randomization: 1) a simple visual retrospective procedure (SVR), 2) a visual retrospective&#xD;
      procedure coupled with a specific cueing intervention (VR-SC), 3) a verbal retrospective&#xD;
      (VbR) and 4) no intervention (control condition).The testing phase will take place 14 days&#xD;
      after the last day of data collection and will consist in a cued recall task and a&#xD;
      recognition task using the pictures obtained by the SenseCam® of the participants.According&#xD;
      to our hypotheses, the vividness of memories will be higher in events subjected to the VR-SC&#xD;
      procedure than in events subjected to the SVR and VbR procedures. This effect is expected for&#xD;
      both patients with schizophrenia and controls participants. Since strategies to enrich memory&#xD;
      details will be explicitly given to the patients when using the VR-SC procedure, we assume&#xD;
      that patients will be able to normalize their scores.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">May 2014</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Specificity of memories recovered by using the SenseCam camera during the trial</measure>
    <time_frame>1 month</time_frame>
    <description>Test the effectiveness of two techniques of cognitive remediation of autobiographical memory using an innovative tool called SenseCam.This specificity will be evaluated by the experimenter by scoring wealth in detail memories reported during the cued recall task</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Schizophrenia Cognition Autobiographical Memory Cognitive Remediation</condition>
  <arm_group>
    <arm_group_label>patient</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Complete questionary remembering the day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy volunteers</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>- Complete questionary, remembering the day</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Questionary</intervention_name>
    <description>Test the effectiveness of two techniques of cognitive remediation of autobiographical memory using an innovative tool called SenseCam ® for patient</description>
    <arm_group_label>healthy volunteers</arm_group_label>
    <arm_group_label>patient</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Questionary</intervention_name>
    <description>Test the effectiveness of two techniques of cognitive remediation of autobiographical memory using an innovative tool called SenseCam ® for healthy volunteers</description>
    <arm_group_label>healthy volunteers</arm_group_label>
    <arm_group_label>patient</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  for both patients and controls&#xD;
&#xD;
          -  male or female willing to participate and who have signed up the legal document&#xD;
&#xD;
          -  under the protection of health insurancefor patients only&#xD;
&#xD;
          -  schizophrenia or schizo-affective disorder according to the DSM-IV&#xD;
&#xD;
          -  TR criteria&#xD;
&#xD;
          -  clinically stable for at least 2 monthsfor controls only&#xD;
&#xD;
          -  no psychiatric history&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  for both patients and controls&#xD;
&#xD;
          -  current severe or unstable somatic illness&#xD;
&#xD;
          -  neurological history (epilepsia, brain injury, brain surgery…)&#xD;
&#xD;
          -  current substance use disorder (DSM-IV-TR)&#xD;
&#xD;
          -  current major depressive disorder (DSM-IV-TR)&#xD;
&#xD;
          -  mental retardation (IQ &lt; 70)&#xD;
&#xD;
          -  pregnancy, breast feeding&#xD;
&#xD;
          -  current legal controlfor patients only&#xD;
&#xD;
          -  treatment comprising benzodiazepines&#xD;
&#xD;
          -  benzodiazepines intake during the last 3 weeksfor controls only&#xD;
&#xD;
          -  psychotropic intake during the last 3 weeks&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabrice Berna, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Les Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fabrice Berna, MD</last_name>
    <email>fabrice.berna@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Berna</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrice Berna, MD</last_name>
      <email>fabrice.berna@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>June 25, 2013</study_first_submitted>
  <study_first_submitted_qc>January 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2014</study_first_posted>
  <last_update_submitted>August 24, 2018</last_update_submitted>
  <last_update_submitted_qc>August 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

